您的位置：

(4R,12aS)-9-((2,4-二氟苯基)氨甲酰)-4-甲基-6,8-二氧代-3,4,6,8,12,12a-六氢-2H-吡啶[1',2':4,5]吡嗪[2,1-b][1,3]恶嗪-7-醇钠盐

COA SDS 产品说明书大包装询价

英文名称：	Sodium;(4r,12as)-9-[(2,4-difluorophenyl)methylcarbamoyl]-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2h-pyrido[5,6]pyrazino[2,6-b][1,3]oxazin-7-olate
英文别名：	dolutegravir sodium; DOLUTEGRAVIR SODIUM; Tivicay; GSK 1349572A; CHEMBL1213165; sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2',4,5]pyrazino[2,1-b][1,3]oxazin-7-olate; (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino-[2,1-b][1,3]oxazine-9-carboxamide sodium salt; CHEBI:76007; GSK1349572A; UNII-1Q1V9V5WYQ; Dolutegravir sodium (JAN/USAN); Dolutegravir sodium [USAN];
CAS No.：	1051375-19-9
分子式：	C20H18N3O5F2-.NA+
分子量：	441.36
纯度：	99%